| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FCX | Common Stock | Options Exercise | $257,187 | +21,667 | +21% | $11.87* | 126,044 | 01 May 2024 | Direct | |
| transaction | FCX | Common Stock | Options Exercise | $264,795 | +22,233 | +18% | $11.91* | 148,277 | 01 May 2024 | Direct | |
| transaction | FCX | Common Stock | Sale | $2,242,333 | -43,900 | -30% | $51.08 | 104,377 | 01 May 2024 | Direct | F1 |
| transaction | FCX | Common Stock | Options Exercise | $509,355 | +42,767 | +41% | $11.91* | 147,144 | 03 May 2024 | Direct | |
| transaction | FCX | Common Stock | Sale | $2,153,259 | -42,767 | -29% | $50.35 | 104,377 | 03 May 2024 | Direct | F2, F5 |
| holding | FCX | Common Stock | 17,207 | 01 May 2024 | By 401(k) | F6 | |||||
| holding | FCX | Common Stock | 18,818 | 01 May 2024 | By Family Trust |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FCX | Options (Right to Buy) | Options Exercise | $0 | -21,667 | -100% | $0.000000* | 0 | 01 May 2024 | Common Stock | 21,667 | $11.87 | Direct | F3 |
| transaction | FCX | Options (Right to Buy) | Options Exercise | $0 | -22,233 | -34% | $0.000000 | 42,767 | 01 May 2024 | Common Stock | 22,233 | $11.91 | Direct | F4 |
| transaction | FCX | Options (Right to Buy) | Options Exercise | $0 | -42,767 | -100% | $0.000000* | 0 | 03 May 2024 | Common Stock | 42,767 | $11.91 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $51.0000 - $51.1750. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| F2 | Amount beneficially owned includes 42,000 Common Stock Restricted Stock Units. |
| F3 | 33.3% exercisable on the date indicated and on each of the next two anniversaries thereof. |
| F4 | 100% vested on 2/6/2022 |
| F5 | The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $50.0650 - $50.5450. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| F6 | Based on plan statement as of December 31, 2023. |